TFF Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	6	17	27	225	318	99
Market Cap Growth	-38.65%	-38.03%	-88.09%	-29.29%	222.43%	-
Enterprise Value	3	11	10	191	283	71
PE Ratio	-	-0.78	-0.84	-7.25	-17.14	-2.69
PS Ratio	6.61	22.63	54.04	2552.69	-	-
PB Ratio	1.10	1.74	1.17	5.81	8.52	3.57
P/FCF Ratio	-1.02	-1.03	-0.93	-7.40	-17.96	-8.80
P/OCF Ratio	-1.03	-1.04	-0.98	-7.61	-19.16	-8.80
EV/Sales Ratio	3.09	15.32	20.92	2169.36	-	-
EV/EBITDA Ratio	-0.62	-0.54	-0.33	-6.18	-15.24	-5.95
EV/EBIT Ratio	-0.61	-0.53	-0.33	-6.16	-15.24	-5.95
EV/FCF Ratio	-0.81	-0.70	-0.36	-6.29	-15.97	-6.30
Debt / Equity Ratio	0.02	0.01	0.01	-	-	-
Debt / EBITDA Ratio	0.00	-0.01	-0.01	-	-	-
Debt / FCF Ratio	-0.01	-0.01	-0.01	-	-	-
Quick Ratio	0.83	2.26	14.69	18.07	26.70	68.42
Current Ratio	1.26	3.13	16.83	19.81	28.41	71.08
Asset Turnover	0.07	0.05	0.02	0.00	0	0
Return on Equity (ROE)	-195.20%	-163.10%	-131.80%	-61.60%	-58.90%	-300.60%
Return on Assets (ROA)	-160.50%	-144.80%	-119.80%	-59.50%	-56.70%	-185.30%
Return on Capital (ROIC)	-381.49%	-226.13%	-137.83%	-82.06%	-50.06%	-43.36%
Earnings Yield	-340.31%	-127.93%	-118.57%	-13.79%	-5.83%	-37.15%
FCF Yield	-254.66%	-97.16%	-107.84%	-13.52%	-5.57%	-11.36%
Buyback Yield / Dilution	-64.94%	-49.48%	-20.78%	-21.52%	-195.80%	-98.20%
Total Shareholder Return	-64.94%	-49.48%	-20.78%	-21.52%	-195.80%	-98.20%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).